Ifp Advisors, Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$6.68 - $9.1 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$7.82 - $9.23 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$8.44 - $12.66 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$7.98 - $12.29 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	SELL	$7.96 - $12.42 $318 - $496	-40 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	40	40 $1,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.